Primary biliary cirrhosis: the future.

Primary biliary cirrhosis: the future. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Primary biliary cirrhosis: the future. Abstract Text:

Primary biliary cirrhosis is a progressive cholestatic liver disease of presumed autoimmune etiology. Patterns of disease are changing with earlier recognition and better access to investigation and treatment. With the convergence of animal, genetic, and clinical studies over the coming years, it is hoped that a greater understanding in the pathophysiology of the disease will translate into improved clinical endpoints for patients.

Primary biliary cirrhosis: the future. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Primary biliary cirrhosis: the future. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Clinics in liver disease

VOLUME: 12

Page Numbers: 473-9

Journal Abbreviation:

ISSN: 1089-3261

DAY: 5

MONTH: May

YEAR: 2008

Primary biliary cirrhosis: the future. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9710002

Primary biliary cirrhosis: the future. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Primary biliary cirrhosis: the future. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Primary biliary cirrhosis: the future.

AFFILIATION: Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst Street, 6B Fell, Room 154, Toronto, Ontario, M5T 2S8, Canada.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Liver Dis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Primary biliary cirrhosis: the future Related Publications

• An integrated model of choices and response times in absolute identification.
• Antimitochondrial antibody-negative primary biliary cirrhosis.
• Antiviral therapy: chronic hepatitis C.
• Compelling EPR evidence that the alternative oxidase is a diiron carboxylate protein.
• Diagnosis and management of cholestatic liver disease.
• Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors.
• Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis.
• Flavianates of lysine.
• Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.
• Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis.
• Internet access overseas.
• Minimization of the impact of a broad bandwidth high-gain nonlinear preamplifier to the amplified spontaneous emission pedestal of the Vulcan petawatt laser facility.
• Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): A cross-sectional study.
• Ocular involvement in acute febrile neutrophilic dermatosis (sweet syndrome): new cases and review of the literature.
• Oral treatment of pernicious anaemia with low doses of H.P.P./1.
• Oral treatment of pernicious anaemia: first fifty cases.
• Postgraduate medical training: getting patients on board.
• Preface.
• Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: Evaluating the role of routine magnetic resonance imaging.
• Primary biliary cirrhosis.
• Primary biliary cirrhosis: the future.
• Recruiting patients for postgraduate medical training in a community family planning clinic: how do patients want to be asked?
• Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin.
• Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: Case reports.
• T regulatory cells and autoimmune liver disease.
• The toxicity of small concentrations of cystine to acid-producing bacteria.
• Three atypical cases of Wilson disease: assessment of the Leipzig scoring system in making a diagnosis.
• Toxic effect of the crystals from agenized zein on certain acid-producing bacteria.
• Treatment of hepatitis B: the next five years.
• What motivates patients to become involved in postgraduate medical training in a family planning clinic?